170 related articles for article (PubMed ID: 32906832)
1. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
Hartl L; Duitman J; Aberson HL; Chen K; Dijk F; Roelofs JJTH; Dings MPG; Hooijer GKJ; Hernanda PY; Pan Q; Busch OR; Besselink MGH; Boerman T; Peppelenbosch MP; Bijlsma MF; Spek CA
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906832
[TBL] [Abstract][Full Text] [Related]
2. C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
Hartl L; Roelofs JJTH; Dijk F; Bijlsma MF; Duitman J; Spek CA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675048
[TBL] [Abstract][Full Text] [Related]
3. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
[TBL] [Abstract][Full Text] [Related]
4. C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration.
Hartl L; Maarschalkerweerd PAF; Butler JM; Manz XD; Thijssen VLJL; Bijlsma MF; Duitman J; Spek CA
Cells; 2022 Oct; 11(21):. PubMed ID: 36359732
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma.
Sowamber R; Chehade R; Bitar M; Dodds LV; Milea A; Slomovitz B; Shaw PA; George SHL
EBioMedicine; 2019 Jun; 44():261-274. PubMed ID: 31078521
[TBL] [Abstract][Full Text] [Related]
6. Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner.
Spek CA; Aberson HL; Duitman J
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203429
[TBL] [Abstract][Full Text] [Related]
7. Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia.
Gigliotti AP; Johnson PF; Sterneck E; DeWille JW
Exp Biol Med (Maywood); 2003 Mar; 228(3):278-85. PubMed ID: 12626772
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of CCAAT/enhancer-binding protein delta mediated by autoregulation is repressed by related gene family proteins.
Tanabe A; Kumahara C; Osada S; Nishihara T; Imagawa M
Biol Pharm Bull; 2000 Dec; 23(12):1424-9. PubMed ID: 11145170
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
12. The dual role of C/EBPδ in cancer.
Hartl L; Duitman J; Bijlsma MF; Spek CA
Crit Rev Oncol Hematol; 2023 May; 185():103983. PubMed ID: 37024021
[TBL] [Abstract][Full Text] [Related]
13. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1.
Huang CS; Chu J; Zhu XX; Li JH; Huang XT; Cai JP; Zhao W; Yin XY
Cancer Lett; 2018 May; 421():63-72. PubMed ID: 29458145
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of CCAAT/enhancer-binding protein-delta (c/EBPdelta) in rat androgen-dependent tissues and human prostate cancer.
Yang G; Gregory CW; Shang Q; O'Brien DA; Zhang YL
J Androl; 2001; 22(3):471-80. PubMed ID: 11330648
[TBL] [Abstract][Full Text] [Related]
15. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
Huang YC; Chang WC; Su JG; Cai JL; Chen CC; Hung JJ; Liu YW
J Biomed Sci; 2007 May; 14(3):407-18. PubMed ID: 17273900
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells.
Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
Oncol Lett; 2017 Jun; 13(6):4322-4326. PubMed ID: 28599433
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein δ in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma.
Hsiao YW; Li CF; Chi JY; Tseng JT; Chang Y; Hsu LJ; Lee CH; Chang TH; Wang SM; Wang DD; Cheng HC; Wang JM
Sci Signal; 2013 Jul; 6(284):ra59. PubMed ID: 23861541
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
19. Activation domains of CCAAT enhancer binding protein delta: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts.
Ji C; Chang W; Centrella M; McCarthy TL
Mol Endocrinol; 2003 Sep; 17(9):1834-43. PubMed ID: 12791769
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
